NCT07349641 2026-04-13
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
5 trialsNCT07257484 2026-03-13
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Weill Medical College of Cornell University
Phase 4 Not yet recruiting
NCT07065552 2026-01-28
Tirzepatide in Obesity-Driven Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase EARLY_PHASE1 Not yet recruiting
NCT07078838 2026-01-16
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT06073184 2025-06-10
WE-FiERCE
University Health Network, Toronto
Phase 2 Not yet recruiting